|
CKD Bio Corp - Comparative Business Analysis Snapshot
Business Description
CKD Bio Corp. The Company's principal activity is the providing of pharmaceutical products. The Company mainly provides antibiotic ingredients, consisting of potassium clavulanates, demethylchlortetracyclines (DMCTs) and rifampicins. It also develops immunosuppressive agents including cyclosporin and tacrolimus, and remedies for diabetes such as acarbose. The Company exports its products to China, the United States, Europe, Southeast Asia, Africa, South America and the Middle East. The Company operates a research laboratory concentrated on the production of therapeutic pharmaceuticals.
Competitor Analysis
This analysis compares CKD Bio Corp with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
